- Home
- AVBP vs MGIC Comparison
AVBP vs MGIC Comparison
Compare AVBP & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- MGIC
- Stock Information
- Founded
- AVBP 2021
- MGIC 1983
- Country
- AVBP United States
- MGIC Israel
- Employees
- AVBP N/A
- MGIC N/A
- Industry
- AVBP
- MGIC Computer Software: Prepackaged Software
- Sector
- AVBP
- MGIC Technology
- Exchange
- AVBP NYSE
- MGIC Nasdaq
- Market Cap
- AVBP 705.8M
- MGIC 682.5M
- IPO Year
- AVBP 2024
- MGIC 1991
- Fundamental
- Price
- AVBP $21.25
- MGIC $15.83
- Analyst Decision
- AVBP Strong Buy
- MGIC Buy
- Analyst Count
- AVBP 7
- MGIC 2
- Target Price
- AVBP $39.29
- MGIC $16.00
- AVG Volume (30 Days)
- AVBP 234.7K
- MGIC 62.5K
- Earning Date
- AVBP 05-12-2025
- MGIC 05-21-2025
- Dividend Yield
- AVBP N/A
- MGIC 3.56%
- EPS Growth
- AVBP N/A
- MGIC 1.33
- EPS
- AVBP N/A
- MGIC 0.76
- Revenue
- AVBP N/A
- MGIC $569,136,000.00
- Revenue This Year
- AVBP $63.13
- MGIC $7.53
- Revenue Next Year
- AVBP N/A
- MGIC $4.89
- P/E Ratio
- AVBP N/A
- MGIC $20.83
- Revenue Growth
- AVBP N/A
- MGIC 6.37
- 52 Week Low
- AVBP $15.47
- MGIC $9.51
- 52 Week High
- AVBP $36.37
- MGIC $16.50
- Technical
- Relative Strength Index (RSI)
- AVBP 59.18
- MGIC 61.97
- Support Level
- AVBP $19.80
- MGIC $14.67
- Resistance Level
- AVBP $20.86
- MGIC $16.43
- Average True Range (ATR)
- AVBP 1.18
- MGIC 0.53
- MACD
- AVBP 0.12
- MGIC 0.01
- Stochastic Oscillator
- AVBP 88.39
- MGIC 69.41
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. It generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel; Europe; Japan, and Other countries.